DE69711845D1 - Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften - Google Patents
Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaftenInfo
- Publication number
- DE69711845D1 DE69711845D1 DE69711845T DE69711845T DE69711845D1 DE 69711845 D1 DE69711845 D1 DE 69711845D1 DE 69711845 T DE69711845 T DE 69711845T DE 69711845 T DE69711845 T DE 69711845T DE 69711845 D1 DE69711845 D1 DE 69711845D1
- Authority
- DE
- Germany
- Prior art keywords
- ced
- ice
- tricyclic compounds
- inhibiting properties
- protease family
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2601196P | 1996-09-12 | 1996-09-12 | |
US71062196A | 1996-09-20 | 1996-09-20 | |
PCT/US1997/016156 WO1998011109A1 (en) | 1996-09-12 | 1997-09-12 | Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69711845D1 true DE69711845D1 (de) | 2002-05-16 |
DE69711845T2 DE69711845T2 (de) | 2002-10-31 |
Family
ID=26700599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69711845T Expired - Fee Related DE69711845T2 (de) | 1996-09-12 | 1997-09-12 | Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0874850B1 (de) |
JP (1) | JP2000501428A (de) |
AT (1) | ATE215953T1 (de) |
AU (1) | AU739496B2 (de) |
CA (1) | CA2237314A1 (de) |
DE (1) | DE69711845T2 (de) |
NZ (1) | NZ330451A (de) |
WO (1) | WO1998011109A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610683B2 (en) * | 1996-09-12 | 2003-08-26 | Idun Pharmaceuticals, Inc. | Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
US6184210B1 (en) | 1997-10-10 | 2001-02-06 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
ATE296812T1 (de) | 1998-03-09 | 2005-06-15 | Vertex Pharma | 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms |
AU755273B2 (en) * | 1998-03-16 | 2002-12-05 | Cytovia, Inc. | Dipeptide caspase inhibitors and the use thereof |
EP1064298B1 (de) | 1998-03-19 | 2008-10-08 | Vertex Pharmaceuticals Incorporated | Caspase inhibitoren |
WO2000055114A1 (en) | 1999-03-16 | 2000-09-21 | Cytovia, Inc. | Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
CN1176941C (zh) | 1999-04-09 | 2004-11-24 | 西托维亚公司 | Caspase抑制剂及其应用 |
ATE266623T1 (de) * | 1999-08-06 | 2004-05-15 | Vertex Pharma | Caspase inhibitoren und deren verwendung |
MXPA02002038A (es) | 1999-08-27 | 2002-10-31 | Cytovia Inc | Acidos alfa-hidroxi substituidores inhibidores de la caspasa y uso de los mismos. |
WO2001027085A1 (en) * | 1999-10-13 | 2001-04-19 | Merck Frosst Canada & Co. | Nicotinyl aspartyl ketones as inhibitors of caspase-3 |
PE20011350A1 (es) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
ES2295171T3 (es) | 2000-06-07 | 2008-04-16 | Vertex Pharmaceuticals Incorporated | Inhibidores de caspasa y sus usos. |
ES2532433T3 (es) | 2004-03-12 | 2015-03-26 | Vertex Pharmaceuticals Incorporated | Proceso y productos intermedios para la preparación de inhibidores de la acetal caspasa aspártica |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
CN101268084A (zh) | 2005-07-28 | 2008-09-17 | 沃泰克斯药物股份有限公司 | 天冬氨酸特异性半胱氨酸蛋白酶抑制剂前体药物 |
US9956260B1 (en) | 2011-07-22 | 2018-05-01 | The J. David Gladstone Institutes | Treatment of HIV-1 infection and AIDS |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504080A (en) * | 1992-10-28 | 1996-04-02 | Bristol-Myers Squibb Co. | Benzo-fused lactams |
AU7186094A (en) * | 1993-06-30 | 1995-01-24 | Ciba-Geigy Ag | Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
-
1997
- 1997-09-12 DE DE69711845T patent/DE69711845T2/de not_active Expired - Fee Related
- 1997-09-12 AT AT97944309T patent/ATE215953T1/de not_active IP Right Cessation
- 1997-09-12 JP JP10513882A patent/JP2000501428A/ja not_active Ceased
- 1997-09-12 WO PCT/US1997/016156 patent/WO1998011109A1/en active IP Right Grant
- 1997-09-12 EP EP97944309A patent/EP0874850B1/de not_active Expired - Lifetime
- 1997-09-12 NZ NZ330451A patent/NZ330451A/xx unknown
- 1997-09-12 CA CA002237314A patent/CA2237314A1/en not_active Abandoned
- 1997-09-12 AU AU45835/97A patent/AU739496B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE69711845T2 (de) | 2002-10-31 |
JP2000501428A (ja) | 2000-02-08 |
AU739496B2 (en) | 2001-10-11 |
EP0874850B1 (de) | 2002-04-10 |
AU4583597A (en) | 1998-04-02 |
CA2237314A1 (en) | 1998-03-19 |
NZ330451A (de) | 2000-01-28 |
WO1998011109A1 (en) | 1998-03-19 |
EP0874850A1 (de) | 1998-11-04 |
ATE215953T1 (de) | 2002-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69711845D1 (de) | Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften | |
MXPA00013014A (es) | Dipe`tidos de oxamilos modificados en el extremo carboxi como inhibidores de la familia ice/ced-3 de proteasas de cisteinas. | |
BR0008584A (pt) | 2-indolil(n-substituìdo)carbonildipeptìdeos modificados no terminal c como inibidores da famìlia ice/ced-3 das cisteìna proteases | |
WO2003072528A3 (en) | (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases | |
IL128940A0 (en) | C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases and pharmaceutical compositions containing them | |
SG158733A1 (en) | Cell adhesion inhibitors | |
EA200000608A1 (ru) | Предотвращение и лечение амилоидогенного заболевания | |
UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
FR12C0077I2 (fr) | Composition pour le traitement des condylomes génitaux | |
DE69625332T2 (de) | Zelladhäsion hemmende verbindungen | |
BG102995A (en) | Green ointment | |
EA200100732A1 (ru) | Противовоспалительные и иммуносупрессорные соединения, ингибирующие клеточную адгезию | |
DE69229552T2 (de) | Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau | |
DE60142313D1 (de) | Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen | |
WO2002057298A3 (en) | C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases | |
HUP9901353A2 (hu) | ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
DK1185293T3 (da) | IL6RIL6-kimær til behandling af neurodegenerative sygdomme | |
MXPA03004450A (es) | Compuestos triciclicos y sus usos. | |
NO20020369L (no) | Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer | |
ES2185310T3 (es) | Agente antivirico herbario. | |
DE50002304D1 (en) | Tyrosin- und tryptophanhaltige peptide als antioxidantien | |
ES2131468A1 (es) | Uso de la melatonina en el tratamiento de las enfermedades neurodegenerativas. | |
DK0566592T3 (da) | Pyrimido-benzothiaziner med lipoxygenasehæmmende virkning | |
ES2127133A1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |